CNR2 antibody (C-Term)
-
- Target See all CNR2 Antibodies
- CNR2 (Cannabinoid Receptor 2 (CNR2))
-
Binding Specificity
- C-Term
-
Reactivity
- Human, Rat, Mouse, Horse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This CNR2 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Sequence
- MVNPVIYALR SGEIRSSAHH CLAHWKKCVR GLGSEAKEEA PRSSVTETEA
- Predicted Reactivity
- Horse: 83%, Human: 100%, Mouse: 79%, Rat: 86%
- Characteristics
- This is a rabbit polyclonal antibody against CNR2. It was validated on Western Blot.
- Purification
- Affinity Purified
- Top Product
- Discover our top product CNR2 Primary Antibody
-
-
- Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- Comment
-
Antigen size: 360 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells." in: The Journal of biological chemistry, Vol. 289, Issue 19, pp. 13079-100, (2014) (PubMed).
: "
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells." in: The Journal of biological chemistry, Vol. 289, Issue 19, pp. 13079-100, (2014) (PubMed).
-
- Target
- CNR2 (Cannabinoid Receptor 2 (CNR2))
- Alternative Name
- CNR2 (CNR2 Products)
- Synonyms
- CNR2 antibody, CB2 antibody, cb2a antibody, cb2b antibody, CB-2 antibody, CX5 antibody, CB2C antibody, CNR2C antibody, CB2-R antibody, cannabinoid receptor 2 antibody, cannabinoid receptor 2 (macrophage) antibody, CNR2 antibody, cnr2 antibody, Cnr2 antibody
- Background
-
The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
Alias Symbols: CB2, CX5
Protein Interaction Partner: GNA15,
Protein Size: 360 - Molecular Weight
- 40 kDa
- Gene ID
- 1269
- NCBI Accession
- NM_001841, NP_001832
- UniProt
- P34972
-